“Declaratory Order: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy).” U.S. Food & Drug Administration. “FDA Clarifies Policies for Compounders as National GLP-1 Supply ...

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published ...

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

GLP-1 agonist drugs like Ozempic and Wegovy have surged in popularity during the last couple of years for their ability to help patients shed weight quickly and potentially reduce inflammation. While ...